CAN508 was an effective AND ATP-competitive inhibitor of CDK9/cyclin T1 with IC50 of 0.35 µM. CAN508 is 38 times more selective for CDK9/cyclin T1 than other CDK/cyclin. CAN508 has antitumor activity.
Molecular Weight:
218.22
Purity:
>99%
CAS Number:
[140651-18-9]
Formula:
C9H10N6O
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted